Results 21 to 30 of about 112,591 (320)

A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment. [PDF]

open access: yes, 2011
BACKGROUND: Leprosy Type 1 reactions are a major cause of nerve damage and the preventable disability that results. Type 1 reactions are treated with oral corticosteroids and there are few data to support the optimal dose and duration of treatment.
Dhakal, Sushmita   +38 more
core   +1 more source

Immediate-Type Hypersensitivity to Succinylated Corticosteroids [PDF]

open access: yes, 2010
Background: Despite their frequent use, systemic corticosteroids have rarely elicited immediate-type reactions. Objective: We report two male patients, aged 26 and 70 years, respectively, with severe immediate-type hypersensitivity secondary to the ...
Raewer, Helen-Caroline   +7 more
core   +1 more source

Iatrogenic meningitis

open access: yesArquivos de Neuro-Psiquiatria, 2013
Iatrogenic meningitis can be caused by a number of mechanisms. The recent case reports of fungal meningitis after application of epidural methylprednisolone caused warning in the medical community.
Eduardo Genaro Mutarelli, Tarso Adoni
doaj   +1 more source

Methylprednisolone Induces Neuro-Protective Effects via the Inhibition of A1 Astrocyte Activation in Traumatic Spinal Cord Injury Mouse Models

open access: yesFrontiers in Neuroscience, 2021
Traumatic spinal cord injury (TSCI) leads to pathological changes such as inflammation, edema, and neuronal apoptosis. Methylprednisolone (MP) is a glucocorticoid that has a variety of beneficial effects, including decreasing inflammation and ischemic ...
Hong-jun Zou   +4 more
doaj   +1 more source

Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy [PDF]

open access: yes, 2015
The aim of this retrospective study of children affected by epileptic encephalopathy was to evaluate seizure frequency, electroencephalographic pattern and neuropsychological status, before and after intravenous methylprednisolone therapy.
G. Randazzo   +14 more
core   +4 more sources

COMPARISON OF INTRA-ARTICULAR METHYLPREDNISOLONE AND KETOROLAC INJECTIONS IN IMPROVING RANGE OF MOTION FOR DIFFERENT SHOULDER JOINT DISORDERS

open access: yesPakistan Armed Forces Medical Journal, 2021
Objective: To compare the efficacy of intra-articular injection of methyl prednisolone with ketorolac for improvement in range of motion in various shoulder joint disorders. Study Design: Quasi-experimental study.
Sumeera Matee   +5 more
doaj   +1 more source

Giant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs)

open access: yesСовременная ревматология, 2013
Giant cell arteritis (GCA) is a well-known vasculitis sensitive to glucocorticoid (GC) immuno-suppression. However, during long-term treatment there may be many adverse reactions that remain a serious problem so far.
Azamat Makhmudovich Satybaldyev
doaj   +1 more source

Long-term follow-up of intratympanic methylprednisolone versus gentamicin in patients with unilateral Menière’s disease [PDF]

open access: yes, 2018
Objectives: To determine whether long term (>48 months) symptomatic vertigo control is sustained in patients with Menie`re’s disease from a previous comparative trial of intratympanic methylprednisolone versus gentamicin, and if the two treatments remain
Bronstein, A.M.   +23 more
core   +1 more source

The impact of intra-sacroiliac joint methylprednisolone injection in the recovery of patients with spondyloarthropathy: a randomized controlled trial

open access: yes, 2022
INTRODUCTION: Spondyloarthropathies are a group of chronic inflammatory diseases with specific clinical symptoms in rheumatic diseases. These patients suffer from pain in the joints.
Movaffagh, Nooshin   +9 more
core   +1 more source

The CRASH trial protocol (Corticosteroid randomisation after significant head injury) [ISRCTN74459797]. [PDF]

open access: yes, 2001
BACKGROUND: Worldwide, millions of people are treated each year for significant head injury. A substantial proportion die, and many more are disabled.
The CRASH trial collaborators   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy